Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06336603
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-29
First Post:
2024-03-11
Brief Title:
A Study Assessing the Efficacy of Combined Use of Clascoterone 1 Cream and Adapalene 03 for the Treatment of Acne
Sponsor:
Sun Pharmaceutical Industries Limited
Organization:
Sun Pharmaceutical Industries Limited
Study Overview
Official Title:
The Combination Use of Winlevi and Adapalene 03 Gel in Real Life Acne Treatment
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Winlevi is the first topical anti androgen and sebum inhibitor approved for acne vulgaris There is no study assessing Winlevi in combination treatment for acne Therefore this study assesses Winlevi with Adapalene 03 gel in combination to emulate real life practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None